Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis
Scandinavian Journal of Gastroenterology, 11/06/09
Hayashi Y et al. – The findings suggest that the recovery of mucosal impairment due to treatment with mesalazine may be associated with the protection of the tight junction protein occludin in DSS–induced colitis.
Related Articles
Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09
Relevance Score: 91%
Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
ScienceDaily, 10/02/09
Relevance Score: 89%
CD4+ T Cells and Lactobacillus casei Control Relapsing Colitis Mediated by CD8+ T Cells
Journal of Immunology, 10/22/09
Relevance Score: 88%
Ischemic Colitis After Endovascular Aortoiliac Aneurysm Repair
Archives of Surgery, 10/20/09
Relevance Score: 88%
Microscopic colitis: a review for the surgical endoscopist
Canadian Journal of Surgery, 10/16/09
Relevance Score: 88%
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin
Digestive Diseases and Sciences, 11/25/09
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Cephalon, 11/24/09
Sponsor
Article Search
Sponsor


See Latest Articles


